11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Join Veristat and hundreds of Clinical Operations/Development/Research and Medical Affairs pharma and biotech representatives in the northeast region for the Clinical Operations in Oncology Trials East 2017 Conference.
Our experts at this conference will explore strategies and review success stories of optimizing clinical processes within oncology trials to ensure effective patient recruitment, trial management and overall trial success.
Key topics of discussion will include:
Meet up with Veristat at booth # 17. Veristat’s experienced teams have helped clients run over 335 Oncology studies for solid tumors, hematologic malignancies and more. Additionally, we’ve worked on over 20 US and European regulatory submission projects for cancer treatments, including many rare cancers.
Schedule a time to speak with Veristat at the event on how we can put our oncology clinical trial and regulatory submission experience to work for you. Fill out the form on the right.
11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...